“…The clinical manifestations of neurocysticercosis are nonspecific and varied and depend on the number, size, age, localization and evolutionary stage of cysticerci in the SNC 6,7 . Thus, the definitive diagnosis of neurocysticercosis should always be considered in an epidemiological context and confirmed by neuro-imaging techniques 3 (computed tomography or nuclear magnetic ressonance) and/ or detection of specific antibodies in cerebrospinal fluid (CSF) [4][5] . Several tests have been used for the immunodiagnosis of neurocysticercosis such as complement fixation (CFT), immunoelectrophoresis (IEE), indirect hemagglutination (IHT), indirect immunofluorescence (IFT), enzymelinked immunosorbent assay (ELISA) and enzyme-linked immunoelectrotransfer blot (EIBT) assay 4,5,7 .…”